The 20 Best Miyoshi Myopathy Doctors Near Me in Ann Arbor, MI

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Knierbein is rated as an Advanced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 125 other conditions, according to our data. Her clinical expertise encompasses Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Knierbein is board certified in Neurology W/Spec Qual Child Neuro and Neuromuscular Medicine.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Advanced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

Dr. Hornyak is Medical Director of Outpatient Pediatric Rehabilitation Services. He serves on the Evidence Based Practice Committee, and chairs the Evidence Committee, for the AAPM&R. He is actively involved in medical education, serving on the steering committee of the UM Academy of Medical Educators. His teaching has been recognized with departmental (Silver Crutch x 4), medical school (inaugural League of Educational Excellence) and university (Provost’s Teaching Innovation Prize) awards. Dr. Hornyak taught the medical portion of the Team-Based Clinical Decision Making course, the first course offered at UM for Inter-professional Education. He frequently serves on graduate student committees in the UM School of Kinesiology as well. Clinically, Dr. Hornyak practices pediatric and adult PMR. Since joining UM, he has been key in the development of multi-disciplinary care clinics for children and adults with neuromuscular diseases. Dr. Hornyak is rated as an Advanced provider by MediFind in the treatment of Miyoshi Myopathy. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Hereditary Sensory Neuropathy Type 1 (HSN1), Cerebral Palsy, and Spasticity. Dr. Hornyak is board certified in Physical Medicine & Rehab.

Dr. Bowman completed her residency in Physical Medicine and Rehabilitation at Wayne State University/Detroit Medical Center in 2017. She then completed a Pediatric Rehabilitation Medicine fellowship at the University of Michigan in 2019. Dr. Bowman sees pediatric patients with a variety of conditions, including TBI, SCI, Cerebral Palsy, Neuromuscular diseases, and other conditions affecting development. Dr. Bowman is rated as an Advanced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Myotonia Congenita, Spasticity, and Spastic Diplegia Infantile Type.

Gary Gallagher, MD completed his undergraduate bachelor of science degree in Industrial and Operations Engineering at the University of Michigan. An interest in health sciences, lead him to attend medical school at Wayne State University of Medicine in Detroit, MI where he received his doctorate of medicine in 2008. He completed residency in neurology and fellowship in neuromuscular medicine at the University of Michigan. During final year of residency, he served as chief resident. Following completion of fellowship, Dr. Gallagher joined the neurology faculty at the University of Michigan.Dr. Gallagher is interested in the clinical care of neuromuscular disease, tele-medicine, electrodiagnostic procedures (EMG and intraoperative monitoring). His clinical time is spent in the outpatient neuromuscular clinic providing longitudinal care for patients and on the inpatient service caring for acute neurologic problems including stroke management, epilepsy, neuromuscular crisis and auto-immune neurologic disease. In addition, he has strong interest in medical trainee education and he serves as the neuromuscular fellowship director at the University of Michigan. Finally, Dr. Gallagher has strong interest in patient safety and quality improvement and oversees departmental efforts to improve. Dr. Gallagher is rated as an Advanced provider by MediFind in the treatment of Miyoshi Myopathy. He is also highly rated in 71 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Multifocal Motor Neuropathy, Inclusion Body Myositis, and Peripheral Neuropathy.

Dr. Schmidt attended medical school at Michigan State University, and completed her residency training in PM&R at the University of Pittsburgh Medical Center where she also served as chief resident. Dr. Schmidt's clinical responsibilities include outpatient practice focusing on transition into adulthood for pediatric patients with disabilities, cerebral palsy, amyotrophic lateral sclerosis and other neuromuscular conditions. Dr. Schmidt is rated as an Advanced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Dysferlinopathy, Spinal Muscular Atrophy (SMA), Spinal Muscular Atrophy Type 3, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

Alecia K Daunter MD is an Associate Professor of Physical Medicine and Rehabilitation. She completed her medical degree, residency, and fellowship training at the University of Michigan. She is board certified in Physical Medicine and Rehabilitation. She joined the Michigan Medicine faculty in 2018.Dr. Daunter's research interests include function and quality of life outcomes in patients with developmental disabilities or pediatric onset medical conditions. Dr. Daunter is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, Spinal Muscular Atrophy with Arthrogryposis, and Rhizotomy. Dr. Daunter is board certified in Pediatric Rehabilitation Medicine and Physical Medicine & Rehab.

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

Dr. Krater focuses his clinical care on caring for and improving quality of life of individuals with functional limitations. His philosophy for medical care is to guide patients to develop the skills and supports to access their communities, to build a life within their communities, and to live as independently as possible. Dr. Krater is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, Dysferlinopathy, and Rhizotomy.

Roger L. Albin, M.D. (Residency 1986), is a professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School. In addition, he serves as chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.Dr. Albin joined the U-M faculty in 1988 as an instructor in the Department of Neurology. He was promoted to assistant professor in 1989; associate professor in 1994; and achieved his current rank of full professor in 2000.After completing his undergraduate degree at Oberlin College in Ohio, Dr. Albin earned his medical degree from the University of Pittsburgh School of Medicine in 1982, and completed his residency at the University of Michigan in 1986. He also completed a movement disorders fellowship in 1988 under Drs. Anne Young and John Penney.His clinical and research interests include the underlying neurobiologic causes of the clinical features of movement disorders, basal ganglia structure and function, Parkinson's disease, Tourette syndrome, dementias, dystonias and Huntington's disease. His laboratory is pursuing work on basic mechanisms of neurodegeneration in Huntington disease using mouse genetic models. Dr. Albin also has participated in neuroprotective clinical trials for both Huntington's disease and Parkinson's disease.The present focus of Dr. Albin's group is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. He is very interested in applying positron emission tomography (PET) imaging methods to improve diagnosis of dementing disorders like Alzheimer's disease. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.Dr. Albin currently serves as a site investigator for the National Institutes of Health (NIH) Exploratory Trials in Parkinson disease (NET-PD) initiative. His work is supported by grants from the NIH, the Michael J. Fox Foundation and the High Q Foundation.A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Experimental Neurology, Neurology and Neurobiology of Disease. Dr. Albin is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, Dementia, and Deep Brain Stimulation. Dr. Albin is board certified in Neurology.

Dr Kahn is a graduate of the University of Rochester School of Medicine and completed his combined residency in internal medicine and pediatrics from the University of Michigan. He then served a year as pediatric chief resident. Dr Kahn’s clinical interests include men’s health, preventive care for the entire family and medical education as well as caring for the underserved. Dr Kahn enjoys the outdoors, baseball, spending time with his family and friends. Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. His clinical expertise encompasses Focal Dystonia, Obesity in Children, Type 2 Diabetes (T2D), and Emery-Dreifuss Muscular Dystrophy.

Dr. Rodriguez is Medical Director of the Wheelchair Seating Clinic and PM&R Administrator in the Michigan Bowel Control Clinic and the Wound Care Clinic. She has been actively involved in research with the Spinal Cord Injury Model System. She has written and collaborated on several research publications and written chapters on SCI sequelae in premier journals and textbooks in PM&R. Dr. Rodriguez has been recognized for her teaching of trainees with the Silver Crutch award. She is the associate SCI fellowship program director. She also serves on the International Standards and Autonomic Standards Committees, two crucial committees of the American Spinal Injury Association that are responsible for development of any new standards documents related to SCI, continuous review and improvement of the existing ASIA documents on neurological and autonomic standards and development and oversight of the International Data Sets project. Dr. Rodriguez is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 43 other conditions, according to our data. Her clinical expertise encompasses Neurogenic Bowel, Paraplegia, Spasticity, and Autonomic Dysreflexia.

Maryam Berri MD, is a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation at the University of Michigan Medical School.Clinical work includes concomitant traumatic brain and spinal cord injury, myelomeningocele, cerebral palsy, and neurogenic bowel disease treatment. She is pursuing research in lactational outcomes and management for those with neurological disease. She has a strong interest in medical education as well as education and optimization in practice management for faculty. She serves as the revenue physician lead for the department. She is an active in the rehabilitation Standards Committee with the American Spinal Injury Association.Dr. Berri received her BS degree from the University of Michigan in 2009, and then in 2013, she graduated from the American University of the Caribbean in Pembroke Pines, FL. She then completed her residency in Physical Medicine and Rehabilitation at Wayne State University followed by subspecialty fellowship in Spinal Cord Injury at the University of Michigan. Dr. Berri is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Autonomic Dysreflexia, Brown-Sequard Syndrome, Spasticity, and Neurogenic Bowel. Dr. Berri is board certified in Physical Medicine & Rehab, Spinal Cord Injury Medicine, and Brain Injury Medicine.

Alan D. Salgado, M.D. is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Salgado grew up in Gainesville, Florida. He graduated Summa Cum Laude from the University of Florida in 2011. Prior to attending medical school, he completed a postbaccalaureate research training fellowship at the National Institutes of Health. In 2016 he graduated from the University of Florida College of Medicine. He completed a preliminary medicine internship at MedStar Georgetown University Hospital, followed by neurology residency at Vanderbilt University Medical Center. He further completed a fellowship in neuromuscular medicine and EMG at Duke University Medical Center.Dr. Salgado joined the neurology faculty at the University of Michigan in 2022. Dr. Salgado is rated as an Experienced provider by MediFind in the treatment of Miyoshi Myopathy. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy Type 3, Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Thrombectomy. Dr. Salgado is board certified in Neurology, Neuromuscular Medicine, and Electrodiagnostic Medicine.